Is Initial CD3+T Cell Dose in Donor Lymphocyte Infusion for Relapsed Hematological Malignancies a Prognostic Determinant?

被引：0
|
作者：
Atilla, Erden [1 ]
Ataca, Pinar [1 ]
Toprak, Selami Kocak [1 ]
Yuksel, Meltem Kurt [1 ]
Topcuoglu, Pervin [2 ]
Arslan, Onder [1 ]
Ozcan, Muhit [1 ]
Demirer, Taner [1 ]
Ilhan, Osman [1 ]
Beksac, Meral [1 ]
Akan, Hamdi [1 ]
Gurman, Gunhan [2 ]
Bozdag, Sinem Civriz [1 ]
机构：
[1] Ankara Univ, Sch Med, Dept Hematol, TR-06100 Ankara, Turkey
[2] Ankara Univ, Fac Med, Dept Hematol, TR-06100 Ankara, Turkey
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Donor Lymphocyte Infusion for Relapsed Hematological Malignancies After Allogeneic Hematopoietic Cell Transplantation: Prognostic Relevance of the Initial CD3+T Cell Dose
    Bar, Merav
    Storer, Barry
    Bruno, Benedetto
    Hari, Parameswaran
    Chauncey, Thomas
    Inamoto, Yoshihiro
    Martin, Paul J.
    Storb, Rainer
    Maloney, David G.
    Sandmaier, Brenda M.
    Flowers, Mary E. D.
    BLOOD, 2012, 120 (21)
  • [2] Donor Lymphocyte Infusion for Relapsed Hematological Malignancies after Allogeneic Hematopoietic Cell Transplantation: Prognostic Relevance of the Initial CD3+ T Cell Dose
    Bar, Merav
    Sandmaier, Brenda M.
    Inamoto, Yoshihiro
    Bruno, Benedetto
    Hari, Parameswaran
    Chauncey, Thomas
    Martin, Paul J.
    Storb, Rainer
    Maloney, David G.
    Storer, Barry
    Flowers, Mary E. D.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (06) : 949 - 957
  • [3] Is there an optimum CD3+T cell dose for donor lymphocyte infusion?
    Bozdag, S. Civriz
    Kircali, E.
    Ataca, P.
    Atilla, E.
    Bay, M.
    Toprak, S. K.
    Yuksel, M. Kurt
    Topcuoglu, P.
    Arslan, O.
    Ozcan, M.
    Demire, T.
    Ilhan, O.
    Akan, H.
    Beksac, M.
    Konuk, N.
    Gutman, G.
    BONE MARROW TRANSPLANTATION, 2015, 50 : 5598 - 5598
  • [4] Donor lymphocyte infusion for relapsed chronic myelogenous leukemia: prognostic relevance of the initial cell dose
    Guglielmi, C
    Arcese, W
    Dazzi, F
    Brand, R
    Bunjes, D
    Verdonck, LF
    Schattenberg, A
    Kolb, HJ
    Ljungman, P
    Devergie, A
    Bacigalupo, A
    Gomez, M
    Michallet, M
    Elmaagacli, A
    Gratwohl, A
    Apperley, J
    Niederwieser, D
    BLOOD, 2002, 100 (02) : 397 - 405
  • [5] Role of donor lymphocyte infusions in relapsed hematological malignancies after stem cell transplantation revisited
    Deol, Abhinav
    Lum, Lawrence G.
    CANCER TREATMENT REVIEWS, 2010, 36 (07) : 528 - 538
  • [6] Donor Lymphocyte Infusion for Relapsed Hematological Malignancies after Unrelated Allogeneic Bone Marrow Transplantation Facilitated by the Japan Marrow Donor Program
    Miyamoto, Toshihiro
    Fukuda, Takahiro
    Nakashima, Marie
    Henzan, Tomoko
    Kusakabe, Shinsuke
    Kobayashi, Naoki
    Sugita, Junichi
    Mori, Takeshi
    Kurokawa, Mineo
    Mori, Shin-ichiro
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (06) : 938 - 944
  • [7] DONOR LYMPHOCYTE INFUSION FOR THE TREATMENT OF RELAPSED HEMATOLOGICAL MYELOID MALIGNANCIES: RESULTS OF A RETROSPECTIVE MULTICENTER STUDY FROM THE EBMT REGISTRY
    Dumeignil, Louis
    Charbonnier, Amandine
    Morel, Pierre
    Marolleau, Jean-Pierre
    Suarez, Felipe
    Robin, Marie
    Poire, Xavier
    De Meuter, Anne
    Devillier, Raynier
    Berceanu, Ana
    Cornillon, Jerome
    Maury, Sebastien
    Chevallier, Patrice
    Chalandon, Yves
    Nguyen-Quoc, Stephanie
    Maillard, Natacha
    Forcade, Edouard
    Bulabois, Claude-Eric
    Sutton, Laurent
    Bay, Jacques-Olivier
    Yakoub-Agha, Ibrahim
    Bazarbachi, Ali
    Loschi, Michael
    Huynh, Anne
    Francois, Sylvie
    Couturier, Marie-Anne
    Mear, Jean-Baptiste
    Konopacki, Johanna
    Castilla-Llorente, Cristina
    Labuissiere-Wallet, Helene
    Lioure, Bruno
    Rubio, Marie-Therese
    Benakli, Malek
    Beguin, Yves
    Mohty, Mohamad
    Ceballos, Patrice
    Contentin, Nathalie
    Turlure, Pascal
    Chantepie, Sylvain
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 345 - 346
  • [8] Donor lymphocyte infusion(DLI) in relapsed, hematologic malignancies after allogeneic stem cell transplantation.
    Lee, KE
    Jung, CW
    Kim, M
    Lee, MH
    Park, K
    Kim, DY
    Yoon, SS
    Park, SA
    Kim, BK
    BLOOD, 2002, 100 (11) : 453B - 453B
  • [9] Overall survival after donor lymphocyte infusion for relapsed haematological malignancies after allogeneic haematopoietic cell transplantation
    Worel, N.
    Kalhs, P.
    Rabitsch, W.
    Mitterbauer, M.
    Woehrer, S.
    Kuzmina, Z.
    Leitner, G.
    Greinix, H. T.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S256 - S256
  • [10] DONOR LYMPHOCYTE INFUSION IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES LEADS TO DIVERSITY OF LEUKEMIA-ASSOCIATED-ANTIGENS-SPECIFIC T CELL RESPONSES AND TO REDUCTION IN REGULATORY T CELL FREQUENCY
    Hofmann, S.
    Schmitt, M.
    Goetz, M.
    Doehner, H.
    Wiesneth, M.
    Bunjes, D.
    Greiner, J.
    HAEMATOLOGICA, 2017, 102 : 447 - 447
12345